These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 15733211)

  • 21. [Advances and related issues in the use of in vitro methods to predict metabolic clearance rate of new drugs].
    Zhang Q; Wang GJ
    Yao Xue Xue Bao; 2007 Oct; 42(10):1023-8. PubMed ID: 18229605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of drug metabolism: species differences and toxicological relevance.
    Graham MJ; Lake BG
    Toxicology; 2008 Dec; 254(3):184-91. PubMed ID: 18824059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strategies to assess the drug interaction potential in translational medicine.
    Persiani S; Larger P
    Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):675-86. PubMed ID: 17014388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting drug-drug interactions in drug discovery: where are we now and where are we going?
    Hutzler M; Messing DM; Wienkers LC
    Curr Opin Drug Discov Devel; 2005 Jan; 8(1):51-8. PubMed ID: 15679172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Applicability of bioanalysis of multiple analytes in drug discovery and development: review of select case studies including assay development considerations.
    Srinivas NR
    Biomed Chromatogr; 2006 May; 20(5):383-414. PubMed ID: 16307470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New horizons in drug metabolism, pharmacokinetics and drug discovery.
    Palmer AM
    Drug News Perspect; 2003; 16(1):57-62. PubMed ID: 12682673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of clearance concepts and modeling techniques in the prediction of metabolic drug-drug interactions.
    Ito K; Sugiyama Y
    Trends Pharmacol Sci; 2010 Aug; 31(8):351-5. PubMed ID: 20542578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implications of the allosteric kinetics of cytochrome P450s.
    Atkins WM
    Drug Discov Today; 2004 Jun; 9(11):478-84. PubMed ID: 15149623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the cytochrome P450 enzymes and enzyme kinetic parameters for metabolism of BVT.2938 using different in vitro systems.
    Baranczewski P; Edlund PO; Postlind H
    J Pharm Biomed Anal; 2006 Mar; 40(5):1121-30. PubMed ID: 16307862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic screening for pharmacokinetic interactions during drug development.
    Fuhr U; Weiss M; Kroemer HK; Neugebauer G; Rameis H; Weber W; Woodcock BG
    Int J Clin Pharmacol Ther; 1996 Apr; 34(4):139-51. PubMed ID: 8861732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytochrome P450-mediated metabolism in the human gut wall.
    Thelen K; Dressman JB
    J Pharm Pharmacol; 2009 May; 61(5):541-58. PubMed ID: 19405992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug interactions.
    Boobis A; Watelet JB; Whomsley R; Benedetti MS; Demoly P; Tipton K
    Drug Metab Rev; 2009; 41(3):486-527. PubMed ID: 19601724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Approach to the prediction of the contribution of major cytochrome P450 enzymes to drug metabolism in the early drug-discovery stage.
    Emoto C; Murase S; Iwasaki K
    Xenobiotica; 2006 Aug; 36(8):671-83. PubMed ID: 16891248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic factors in drug metabolism.
    Belle DJ; Singh H
    Am Fam Physician; 2008 Jun; 77(11):1553-60. PubMed ID: 18581835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The P450 enzyme system: a key to understanding the metabolism of drugs.
    Bakutis AR
    AANA J; 1983 Jun; 51(3):272-4. PubMed ID: 6613503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lead optimization strategies as part of a drug metabolism environment.
    Korfmacher WA
    Curr Opin Drug Discov Devel; 2003 Jul; 6(4):481-5. PubMed ID: 12951811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver enzyme induction and inhibition: implications for anaesthesia.
    Sweeney BP; Bromilow J
    Anaesthesia; 2006 Feb; 61(2):159-77. PubMed ID: 16430569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of parallel pathways of drug elimination and multiple cytochrome P450 involvement on drug-drug interactions: CYP2D6 paradigm.
    Ito K; Hallifax D; Obach RS; Houston JB
    Drug Metab Dispos; 2005 Jun; 33(6):837-44. PubMed ID: 15897600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting drug-drug interactions from in vitro drug metabolism data: challenges and recent advances.
    Obach RS
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):81-9. PubMed ID: 19152216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pivotal role of hepatocytes in drug discovery.
    Soars MG; McGinnity DF; Grime K; Riley RJ
    Chem Biol Interact; 2007 May; 168(1):2-15. PubMed ID: 17208208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.